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multiple sample assessments was limited and considered acceptable in the
context of logistics, scarcity of samples, and costs (triplicate assessment in
a subset of samples showed high correlation between biochemical marker
concentrations in the ﬁrst sample and the mean concentration in triplets; rs
0.841 - 0.996, P 0.000). Of the 11,000 assessments that were performed, 27
and 19 assessments showed concentrations that were below and above the
standard curve, respectively. Re-assessment in adjusted dilutions induced
(unpredictable) non-linear dilution effects and was considered inappro-
priate. Instead, artiﬁcial concentrations (0.8×minimum, 1.2×maximum
concentration) were used. Technically-induced variability increased stepwise
between the 3 levels (intra-plate<within day<total), but not statistically
signiﬁcantly. Correction for between-plate variability on the basis of compar-
ison of the standard sample assessment between assay plates decreased the
mean sum of squared differences between plates by a factor 1.5 (mean; SD
0.9). Three of the 11 biomarkers showed unanticipated results. One could be
re-assessed successfully, the other 2 remained unsolved, despite thorough
analyses in consultancy with the manufacturer.
Conclusions: Large-scale and broad-spectrum biochemical marker assess-
ment poses speciﬁc challenges. However, this study shows that large-scale
assessment was feasible for the vast majority of the studied biochemical
markers.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
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Purpose: In longitudinal studies like in osteoarthritis, serum samples are
collected over time, freezed (at-20°C) or deep-freezed (at -75°C or more),
and then simultaneously analyzed in order to minimize inter-assay vari-
ability. Unfortunately not much information has been published about the
impact of freezing and storage duration on biomarkers. In this study, we
investigated whether repeated freeze-thaw cycles or duration and temper-
ature of cryopreservation have an effect on the concentration of MMP-7,
TIMP-1, VEGF and VEGF-R2 measured in serum by ELISA.
Methods: Concentrations of biomarkers were measured by ELISA (R&D)
in the sera of patients with rheumatoid arthritis. To test stability, the
samples were frozen and thawed up to 6 times (0, 1, 3 and 6). Impact
of storage time/temperature was investigated using accelerated stability
testing protocol keeping samples at +4°C, +20°C, +30°C and +40°C up to 3
weeks. The stability for storage at -20°C and at -75°C was calculated using
Arrhenius equation (Kenis, G. et al., 2002) and the stability was expressed
as the period of time preserving at least 90% of the initial level of the
biomarker.
Results: One thawing cycle did not change signiﬁcantly concentration of
MMP-7 and VEGF-R2 measured by ELISA. But the level of these biomarkers
increased 20-24% after repeated thawing (3 or more cycles). The average
concentration of TIMP-1 decreased less than 13% even after 6 cycles of
thawing/freezing, but remarkable heterogeneity in deviation (increasing
or decreasing) from initial level was seen between individual sera. The
decrease in VEGF concentration (average 67%, from 30 to 95%) was very
remarkable even already after the ﬁrst thawing/freezing cycle.
The results of accelerated aging experiments were used to calculate the
liable concentration changes in cryopreservation of investigated biomark-
ers. According to Arrhenius’ calculation MMP-7 showed excellent stability
(at least 11 years at -20°C and several hundreds of years at -75°C !).
TIMP-1 keeps 90% of initial concentration at -20°C within one month and
10 months at -75°C. VEGF- R2 was more stable than VEGF and preserved at
-20°C within three months and at -75°C - 32 years (VEGF - one month and
4 months, respectively).
Conclusions: The conditions of storage of human sera in biobank should
be taken into account in the interpretation of the concentration of MMP-7,
TIMP-1, VEGF or VEGF-R2. Temperature -20 °C is not suitable for prolonged
storage of investigated biomarkers, except MMP-7.
VEGF-R2 and MMP-7 can be assessed in serum samples kept at -75 °C for
several decades. Repeated freezing of sera is not recommended as it may
increase the measured level of these biomarkers.
Assessment of TIMP-1 should be done within 10 months of storage at -75
°C. VEGF is not marker to test in cryopreserved sera as it is not stable at
thawing/freezing.
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Purpose: In osteoarthritis (OA), many studies were focused in ﬁnding one
or more biomarkers reﬂecting the importance and the disease progression.
The aim of our study was to validate a number of these biomarkers.
Methods: Serum samples and fresh blood were obtained from 30 patients
with severe knee osteoarthritis (score of Kellgren/Lawrence K/L at least
3/4), 12 moderate knee OA patients (score of K/L less than 3) and 12
healthy donors as controls. We analyzed the systemic expression of CRP,
COMP, MMP-1 and MMP-3, osteocalcin, OPG, and CTX-I in the 3 groups
of patients by ELISA technique. Statistical analysis used the nonparametric
Wilcoxon test.
Results: OA patients had a mean age of 71 years, had a mean radiological
score of K/Lawrence of 3.8 and their pain has evolved over 7 years. Respec-
tively, moderate OA patients had 62 years, K/L score of 1,5 and 6 years
of pain. Compared to controls subjects, we found a signiﬁcant association
between the presence of a severe knee OA and serum levels of CRP (mean
8.8 vs 1.7 mg/L; p<0.001), OPG (mean 7.9 vs 5.4 ng/mL; p<0.001), MMP-3
(mean 32.4 vs 20.6 ng/mL; p<0.05) and COMP (mean 2.55 vs 2.05 μg/mL;
p<0.01). This association also exists with a low serum CTX-I (mean 0.42 vs
0.61 ng/mL; p<0.05). There was also a signiﬁcant association between the
presence of a moderate knee OA and serum levels of CRP (mean 2.6 vs 1.7
mg/L), OPG (mean 6.4 vs 5.4 ng/mL) and COMP (mean 2.43 vs 2.05 μg/mL)
(p<0,05). However, we did not ﬁnd any signiﬁcant association with low
levels of serum CTX-I or high levels of MMP-3.
Conclusions: Our results show the sensitivity of some biomarkers (bone,
cartilage or inﬂammation) to distinguish OA patients from healthy subjects.
Future work is needed to understand the pathophysiological mechanisms
involved in OA, particularly towards RANKL/OPG.
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Purpose: The purpose of this study was to establish the sedc heterozy-
gous (s/+) mouse as a new non-dwarfed, murine model for the study
of osteoarthritis (OA). In addition, this study was done to determine the
involvement of the HtrA-1, DDR-2 and MMP-13, known biomarkers of OA,
in the degenerative pathway of articular cartilage (AC) in the s/+ mouse
as compared to the wild-type (+/+) mouse. HtrA-1 is involved in the
destruction of the pericellular matrix surrounding chondrocytes. DDR-2 is
a cell membrane receptor protein that binds to type II collagen and triggers
the upregulation of MMP-13, which hydrolyzes type II collagen and some
proteoglycans.
Methods: The sedc heterozygote knee joint was analyzed using histological
techniques. To compare skeletal development of the s/+ mouse compared
with +/+ controls, full skeletal staining was done and 2 week growth
plates were analyzed using safranin O and fast green. Tissue sections from
mice at 2, 6, 9, 12 and 18 months of age were stained with safranin O
and fast green and analyzed with a modiﬁed Mankin scoring procedure
to compare the severity of OA in the s/+ knee joint with +/+ controls.
Immunohistochemistal (IHC) staining was used to identify the correlation
between OA and the relative upregulation of HtrA-1, DDR-2 and MMP-13.
Results: The sedc heterozygous mouse was phenotypically identical to +/+
controls in skeletal and gowth plate staining. Skeletal development was
normal, however, Mankin scoring showed a signiﬁcantly higher score in s/+
mice compared to +/+ controls at all ages. Scoring increased uniformly from
2 to 18 months. Safrinin O and fast green staining showed proteoglycan
degradation starting as early as 2 months and ﬁbrillation starting as early
as 9 months, but primarily occurring at 12 months. IHC showed that
